(Q47235663)

English

Enoxaparin, a low molecular weight heparin decreases infarct size and improves sensorimotor function in a rat model of focal cerebral ischemia

scientific article published in July 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10876084

Enoxaparin, a low molecular weight heparin decreases infarct size and improves sensorimotor function in a rat model of focal cerebral ischemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10876084

cerebral infarction

1 reference

based on heuristic

inferred from title

author name string

Quartermain D

1

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10876084

Li Y

2

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10876084

Jonas S

3

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10876084

language of work or name

0 references

publication date

1 July 2000

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10876084

Neuroscience Letters

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10876084

288

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10876084

2

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10876084

155-158

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10876084

Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901223-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901223-4

7 January 2021

based on heuristic

inferred from DOI database lookup

To what extent have functional studies of ischaemia in animals been useful in the assessment of potential neuroprotective agents?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901223-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Is low molecular weight heparin a neuroprotectant?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901223-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901223-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Posttreatment with low molecular weight heparin reduces brain edema and infarct volume in rats subjected to thrombotic middle cerebral artery occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901223-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversible middle cerebral artery occlusion without craniectomy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901223-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901223-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Heparinoids with low anticoagulant potency attenuate postischemic endothelial cell dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901223-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of brain injury using heparin to inhibit leukocyte accumulation in a rat model of transient focal cerebral ischemia. I. Protective mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901223-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0304-3940(00)01223-4

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10876084

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10876084

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47235663&oldid=2147243847"